| Logo | Name | Σ | ||
|---|---|---|---|---|
 | CNRS Innovation Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS … Sectors: | 434 | 118 | 315 |
 | CNRS The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, and Science Sectors: | 2655 | 2113 | 307 |
 | Hello Tomorrow Building a collaborative ecosystem that leverages the power of deep technologies to tackle world challenges. Hello Tomorrow was created in 2011 by a group of individuals convinced that science and technology need to form part of a toolkit of solutions to change our industries, sustain a growing population and help solve global crises. But the traditional model of technology transfer to bring solutions from lab to market, and from idea to impact, could not rise to this challenge. In turn, Hello Tomorrow has built, and now animates, a global ecosystem that facilitates ‘deep tech’ innovation through multiple activities. Over the … Sectors: | 475 | 314 | 180 |
 | Cryoport Systems (formerly Cell&Co) A Cryoport Company - ATMP & Clinical sample management - www.cell-and-co.com Expert in GMP products management & Clinical sample management activities, Cell&Co BioServices, subsidiary of Cryoport Systems, offers a complete one-stop-shop solution for managing GMP-products and biological-samples. Our mission is to give you a reliable solution of storage, packaging, traceability, and trustfull logistic services. Cell&Co is the first and most important french private biorepository ; recognized, certified and having regulatory authorizations, with the highest and non challenged capacity. With two GMP plants, Cell&Co is offering mirroring storage capacities from -196°C to +20°C. We mainly support our clients by providing the … Sectors: | 16 | 9 | 8 |
 | XAnge XAnge is top European early-stage VC, BCorp certified, with €650m AUM and invests in digital, deeptech & impact startups XAnge (xange.vc) is a leading European venture capital firm, Bcorp certified, based in Paris, Berlin, and Munich. With €650M Assets under Management, the company invests in European early-stage innovative technology companies operating in the fields of Digital consumer, Enterprise & Data, Fintech, and Deeptech. Since its creation in 2003, XAnge has backed more than 200 fast-growing companies in their entrepreneurial journeys. The team works alongside visionary founders with strong values and international ambitions such as Ledger, Odoo, Lydia, or Believe Digital. … Sectors: | 520 | 238 | 286 |
 | MEDICALPS [Automatic translation follows] The Alpine Arc Health Technology Cluster MEDICALPS is the Alpine Arc health technology cluster. Since 2000, the association has brought together and represented a network of more than 130 start-ups, SMEs, large groups, research centers, universities and communities from the fields of medical technologies, biotechnologies and e-health. The leadership of MEDICALPS, facilitator and unifier of this community, is largely entrusted to entrepreneurs, with the support of public stakeholders, with the aim of building the medicine of tomorrow. The association's operational programs serve the growth and visibility of the network of industrialists in the field of health technologies … | 179 | 65 | 138 |
 | Gouvernement The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players ! | 1873 | 1199 | 562 |
 | Eurazeo Eurazeo is a leading global investment group Eurazeo is a leading global investment company, with a diversified portfolio of €34.1 billion in assets under management, including nearly €24.1 billion from third parties, invested in 590 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 410 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free … Sectors: | 479 | 298 | 202 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 10261 | 7996 | 1200 |
 | bioMérieux Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. … Sectors: | 289 | 214 | 52 |
 | Institut Curie [Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing … Sectors: | 541 | 406 | 94 |
 | Pierre Fabre Group New ways to care Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: | 477 | 339 | 108 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 2274 | 1683 | 466 |
 | Centre-Val de Loire Region [Automatic translation follows] Activity, employment, environment, solidarity at the heart of the Centre-Val de Loire Region's challenges for the future A flagship location for creation, innovation and the art of living, the Centre-Val de Loire region has been, since the Renaissance, the one that best embodies the Nature-Culture and Heritage DNA. Strongly marked by its agriculture, the Centre-Val de Loire region is one of the leading cereal regions in Europe. It is also renowned for its internationally renowned competitiveness clusters: the Cosmetic Valley (perfumery and cosmetics), the Electrical Energy Sciences and Systems cluster (renewable energies, intelligent buildings and electrical equipment … Sectors: | 1495 | 1031 | 234 |
 | Région Auvergne-Rhône-Alpes [Automatic translation follows] #auvergnerhonealpes Auvergne-Rhône-Alpes is a large region with many assets: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th most populated region in Europe - Covering nearly 70,000 km2, or 13% of the metropolitan territory, its surface area is equivalent to that of Ireland. - In France, it is the leading industrial and gastronomic region, it ranks first for agricultural production under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe … Sectors: | 3119 | 2493 | 453 |
 | PMT [Automatic translation follows] Innovation Catalyst & Business Accelerator in BFC A competitiveness cluster since 2005, the PMT catalyzes innovation, accelerates business and supports the transitions of industries in Bourgogne-Franche-Comté. Since 2017, it has brought together, through its PMT Santé and PMT ASD clusters, the health technology sectors on the one hand and the aeronautics-space-defense sectors on the other, resulting from excellence in microtechnology. It has also developed strong expertise in support dedicated to start-ups and innovative companies through its PMT Propulseur accelerator. Microtechnology, Health, Aeronautics, Defense, Space, Precision mechanics, Luxury, Innovation, International, Labeling, Training, Medical, Bourgogne-Franche-Comté, and Precision mechanics Sectors: | 278 | 78 | 236 |
 | Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total turnover of pharmaceuticals in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in … Sectors: | 571 | 319 | 211 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 482 | 264 | 329 |
 | Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: | 402 | 215 | 237 |
 | Eurobiomed [Automatic translation follows] The key partner of future leaders in health Eurobiomed is the competitiveness cluster of the health sector bringing together the Provence Alpes Côte d'Azur and Languedoc-Roussillon regions. Created on January 1, 2009, the Cluster was recognized as a very high-performing cluster following the audit carried out in 2012 by the state, the results are there in number and amounts of projects financed, growth in turnover, growth in exports, direct jobs created and maintained by member companies. The Eurobiomed territory constitutes a large European region of health, It is also ranked second nationally for the density of public … Sectors: | 299 | 157 | 157 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: | 357 | 131 | 282 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 689 | 389 | 442 |
 | Clermont Auvergne Innovation [Automatic translation follows] Innovation Accelerator Clermont Auvergne Innovation, a valorization subsidiary, is tasked with providing the interface between the research laboratories of the Université Clermont Auvergne et Associés and its partners, including companies, by simplifying and accelerating collaboration processes in order to increase the number of these interactions. Our goal is to promote the assets and skills of the scientific community to companies until the creation of Deeptech start-ups. Technology Transfer, Maturation of Innovative Technologies, and Protection of Invention Patents Sectors: | 75 | 25 | 42 |
 | CEA Tech From research to industry At CEA Tech we feel strongly that technology research is a crucial component of both innovation and value creation. It is this belief that has driven our successful technology development activities over the past 50 years. CEA Tech is the CEA’s (the French Atomic Energy and Alternative Energy Commission) technology research unit. CEA Tech’s three labs—Leti, Liten, and List—develop a broad portfolio of technologies for ICTs, energy, and healthcare. CEA Tech leverages a unique innovation-driven culture and unrivalled expertise to develop and disseminate new technologies for industry, effectively bridging the gap between the worlds of research … | 89 | 63 | 7 |
 | CEA The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and … Sectors: | 2175 | 1455 | 270 |
 | Linksium Detecting promising #deeptech and fostering the creation of #startups with Grenoble Alpes IP inside . Linksium, Société d’Accélération du Transfert de Technologies (SATT) de Grenoble Alpes détecte projets prometteurs issus de la recherche publique, finance et accompagne la création de startups #deeptech. Detecting promising technologies, funding and fostering the creation of deeptech #startups in the French Alps area. Technology transfert, Startups building, deeptech, venture capital, Research & development , and R&D Tags: SATT Network | 265 | 94 | 163 |
 | La French Tech La French Tech désigne tous les acteurs de l’écosystème de start-up françaises, soutenu par la Mission French Tech. 🇫🇷 La French Tech est la marque déployée par l’Etat français qui représente l’écosystème de 25 000 start-up français et de tous les acteurs qui gravitent autour (fonds d’investissement, associations, acteurs publiques, etc.), soutenu par la Mission French Tech (administration rattachée à la Direction Générale des Entreprises, au sein du ministère de l’Economie, des Finances et de la Souveraineté industrielle et numérique). Elle a pour mission d’accompagner le développement de l’écosystème French Tech, mouvement français des start-up technologiques innovantes, dans la lignée … Sectors: | 3288 | 2066 | 1266 |
 | BASF We create chemistry for a sustainable future At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/en/tools/legal/credits.html Data … | 2222 | 1553 | 171 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: | 796 | 565 | 223 |
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: | 3541 | 1958 | 1725 |
 | Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: | 355 | 199 | 53 |
 | Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: | 754 | 611 | 55 |
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: | 946 | 583 | 195 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: | 530 | 459 | 33 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: | 1305 | 1106 | 117 |
 | UCB Inspired by patients. Driven by science. UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and … | 233 | 173 | 56 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: | 2701 | 1781 | 321 |
 | Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: | 2956 | 1910 | 369 |
Research